ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

News

News

Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.

Up until now, these treatments have not produced promising efficacy results in clinical trials. MRI could show the way.

As more treatments become available, patients will have more preferences and will play a more prominent role in directing choices.

Some very recent research findings have added to the literature on the associations between migraine and depression, anxiety, and other disorders. Highlights here.

Determining who is at risk for MS remains difficult, and symptoms may take time to develop even in patients who already have some destroyed myelin. MRI may help.

New study findings do not suggest a need for a change in vaccine policy, but even a small increased risk could have an effect on public health.

The notion that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease was confirmed by the results of the largest study of its kind.

Pages

Subscribe to News on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.